Subgroup analyses in confirmatory clinical trials: time to be specific about their purposes
BACKGROUND: It is well recognized that treatment effects may not be homogeneous across the study population. Subgroup analyses constitute a fundamental step in the assessment of evidence from confirmatory (Phase III) clinical trials, where conclusions for the overall study population might not hold....
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757983/ https://www.ncbi.nlm.nih.gov/pubmed/26891992 http://dx.doi.org/10.1186/s12874-016-0122-6 |